Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who understand what the study involves and are willing to sign and date a consent form before any study-related procedures begin.
- People who are willing and able to follow all of the study's procedures and requirements.
- People who have been taking a direct anticoagulant (a type of blood-thinning medication) daily, at a standard dose, up to and including recently.
- People who are not taking any other blood-thinning medications alongside their direct anticoagulant, such as aspirin (acetylsalicylic acid), clopidogrel, ticagrelor, low molecular weight heparin, or a second direct anticoagulant.
Who may not be able to join:
- People who have a significant medical or psychiatric condition, or a relevant medical history, that the study doctor believes could affect their ability to participate or could increase health risks for them during the study.
- People who have recently been taking any other blood-thinning medications in addition to a direct anticoagulant, such as aspirin (acetylsalicylic acid), clopidogrel, ticagrelor, low molecular weight heparin, or a second direct anticoagulant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eva Vlckova, MD, Masaryk University, University Hospital Brno
Phone: +420532232503
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intramuscular hematoma risk
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.